← Back
Data updated: Jul 17, 2026
ECI PHARMS LLC
Pharma Pharmaceuticals
ECI PHARMS LLC is a pharmaceutical company with 2 FDA-approved products.
2018
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
ECI PHARMS LLC's Key Drugs
ECI PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
ECI PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for ECI PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
ECI PHARMS LLC's Therapeutic Areas
Disease areas where ECI PHARMS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ECI PHARMS LLC Pipeline Snapshot
Active clinical trials for ECI PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2018-04-25
- Latest
- 2025-12-22
- Applications
- 2